This article is a correction to:
The rationale for the treatment of long-Covid symptoms – A cardiologist's view
Elisabeth SchiefferBernhard Schieffer*
- Department of Cardiology, Angiology and Critical Care Medicine, University Hospital Marburg (UKGM), Philipps University Marburg, Marburg, Germany
A Corrigendum on
The rationale for the treatment of long-COVID symptoms—a cardiologist’s view
By Schieffer E and Schieffer B. (2022) Front Cardiovasc Med. 9:992686. doi: 10.3389/fcvm.2022.992686
In the published article, there was an error in the article type. It was incorrectly published as a Systematic Review. The correct article type is: Perspective.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: lipid – hybrid nanoparticles, HDL - cholesterol, long-Covid syndrome, histamin challenge, cholesterol, renin-angiotensin system, kalkrein-kinin system
Citation: Schieffer E and Schieffer B (2023) Corrigendum: The rationale for the treatment of long-COVID esymptoms—a cardiologist's view. Front. Cardiovasc. Med. 10:1244340. doi: 10.3389/fcvm.2023.1244340
Received: 22 June 2023; Accepted: 22 June 2023;
Published: 21 July 2023.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
© 2023 Schieffer and Schieffer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bernhard Schieffer Bernhard.Schieffer@staff.uni-marburg.de